Hong Kong stocks of innovative drug stocks strengthened sharply in early trading. WuXi AppTec (02359.HK) reported a profit warning and rose more than 10%, WuXi Hepharm (02268.HK) rose more than 7%, and stocks such as Boan Biopharm (06955.HK) and Hengrui Medicine (01276.HK) followed suit.

2025-07-11 09:39:11

WuXi AppTec

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Oppenheimer: Raises Nvidia (NVDA.O) price target from $175 to $200.
                            2025-07-15

                                    Shanghai: Accelerate the implementation of major engineering projects and build core capabilities of the smart glasses industry
                            2025-07-15

                                    ETF Midday Review: ChiNext Artificial Intelligence ETF Southern led the gains by 4.95%, while the CSI 2000 ETF Fund led the losses by 4.36%
                            2025-07-15

                                    Tesla Model Y long-range rear-wheel drive version is priced at about RMB 567,000 in India
                            2025-07-15

                                    BOE A: Will submit a review to the ITC regarding the preliminary ruling of the 337 investigation on trade secrets
                            2025-07-15